BROOKE TOBIA: Open Payments
NPI 1568740918 · STERLING HEIGHTS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,927 in 233 payments from 27 companies in 2025. Trend: 2023 $3,004 · 2024 $2,968 · 2025 $3,927
Food & beverage: $3,927
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $428 |
| Novo Nordisk Inc | 27 | $405 |
| Amgen Inc. | 26 | $373 |
| PFIZER INC. | 22 | $362 |
| AstraZeneca Pharmaceuticals LP | 13 | $341 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $227 |
| Esperion Therapeutics, Inc. | 15 | $193 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $187 |
| Axsome Therapeutics, Inc. | 13 | $179 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $152 |
Products named: VRAYLAR, Kerendia, OTEZLA, NEXLETOL, CAPLYTA, PREVNAR 20, Auvelity, BREZTRI.
Industry payments across MI — which companies pay providers there.
